Wednesday, June 19, 2024

Polaris of Enlightenment

Wednesday, June 19, 2024

Polaris of Enlightenment

Vaccine-injured trial patient sues Astra Zeneca

Published 18 May 2024
- By Editorial Staff
Dressen describes herself as "a shadow of my former self".

Brianne Dressen says she suffered permanent injuries after participating in clinical trials of Astra Zeneca’s covid vaccine. The pharmaceutical company has promised to pay any hospital costs, but this has not yet happened.

The 42-year-old participated in clinical trials of Astra Zeneca’s covid-19 vaccine in the United States in 2020. That same evening, she started experiencing symptoms of pain all over her body, which felt like being stuck by needles, and was later diagnosed with peripheral neuropathy, a condition that causes numbness and pain due to damaged nerves. It was found to be caused by AstraZeneca’s Covid vaccine and the condition has been classified as “post-vaccine neuropathy”. The clinical trials for the covid vaccine were not approved in the US.

Before the trials, she had signed an agreement with the company promising to “pay the costs of medical treatment for research injuries”, which Dressen claims the company did not do.

Now, Dressen is suing the pharmaceutical company because they did not pay any hospital costs, reports The Telegraph. She says she has paid thousands of dollars in hospital bills herself and is unable to work because of her condition.

I’m still permanently disabled, she said.

Acknowledged serious side effects

In the UK, the pharmaceutical company has been sued by over 40 people after allegations that the vaccine caused deaths and serious side effects. Astra Zeneca, which previously denied these claims, recently admitted that the vaccine can cause thrombosis with thrombocytopenia syndrome (TTS), which includes blood clots and low platelet levels.

In the lawsuit, Dressen says she is “a shadow of her former self: unable to work, unable to do any athletic activity, unable to parent the way she had, and unable to drive more than a few blocks at a time“.

The lawsuit is the first of its kind in the US. The pharmaceutical company has not commented on the case at this time.

TNT is truly independent!

We don’t have a billionaire owner, and our unique reader-funded model keeps us free from political or corporate influence. This means we can fearlessly report the facts and shine a light on the misdeeds of those in power.

Consider a donation to keep our independent journalism running…

Share via